                         SEQUENCE LISTING

<110>  Turnstone Biologics Inc.
       Children's Hospital of Eastern Ontario Research Institute Inc.
 
<120>  METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS

<130> PAT 106000W-90

<140>  TBA
<141>  On even date herewith

<150>  US 62/821,397
<151>  2019-03-20

<150>  US 62/892,532
<151>  2019-08-27

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MC-38-derived neoantigen - Adpgk

<400>  1

Ala Ser Met Thr Asn Met Glu Leu Met 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MC-38-derived neoantigen - Reps1

<400>  2

Ala Gln Leu Ala Asn Asp Val Val Leu 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MC-38-derived neoantigen - Irgq

<400>  3

Ala Ala Leu Leu Asn Ser Ala Val Leu 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MC-38-derived neoantigen - Cpne1

<400>  4

Ser Ser Pro Tyr Ser Leu His Tyr Leu 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MC-38-derived neoantigen - Aaltf 

<400>  5

Met Ala Pro Ile Asp His Thr Thr Met 
1               5                   


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  B16.F10-derived neoantigen - Obsl1

<400>  6

Leu Cys Pro Gly Asn Lys Tyr Glu Met 
1               5                   


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  B16.F10-derived neoantigen - Snx5 

<400>  7

Ala Ala Phe Gln Lys Asn Leu Ile Glu Met 
1               5                   10  


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  B16.F10-derived neoantigen - Pbk

<400>  8

Ala Ala Val Ile Leu Arg Asp Ala Leu 
1               5                   


<210>  9
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  B16.F10-derived neoantigen - Atp11a

<400>  9

Gln Ser Leu Gly Phe Thr Tyr Leu 
1               5               


<210>  10
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  B16.F10-derived neoantigen - Eef2

<400>  10

Val Lys Ala Tyr Leu Pro Val Asn Glu Ser Phe Ala Phe Thr Ala 
1               5                   10                  15  


<210>  11
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Maraba N52-59 peptide 

<400>  11

Arg Gly Tyr Val Tyr Gln Gly Leu 
1               5               


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  FMT N301-309 peptide

<400>  12

Ala Val Val Leu Met Phe Ala Gln Cys 
1               5                   


